Related Experiment Video
Updated: Nov 7, 2025

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Membrane Carriers and Transporters in Kidney Physiology and Disease
Marek Drozdzik1, Maria Drozdzik2, Stefan Oswald3
1Department of Experimental and Clinical Pharmacology, Pomeranian Medical University, 70-111 Szczecin, Poland.
Abstract:
The growing information suggests that chronic kidney disease may affect expression and function of membrane carriers and transporters in the kidney. The dysfunction of carriers and transporters entails deficient elimination of uremic solutes as well as xenobiotics (drugs and toxins) with subsequent clinical consequences. The renal carriers and transporters are also targets of drugs used in clinical practice, and intentional drug-drug interactions in the kidney are produced to increase therapeutic efficacy. The understanding of membrane carriers and transporters function in chronic kidney disease is important not only to better characterize drug pharmacokinetics, drug actions in the kidney, or drug-drug interactions but also to define the organ pathophysiology.
Insights
Chronic kidney disease impacts kidney membrane transporters, impairing the elimination of waste products and drugs. Understanding these transporter changes is crucial for managing drug interactions and kidney disease pathophysiology.
Area of Science:
- Nephrology
- Pharmacology
- Molecular Biology
Background:
- Chronic kidney disease (CKD) is increasingly linked to altered expression and function of renal membrane carriers and transporters.
- Dysfunctional transporters in CKD lead to impaired clearance of uremic solutes, xenobiotics (drugs, toxins), and have significant clinical implications.
Purpose of the Study:
- To investigate the role of membrane carriers and transporters in the pathophysiology of chronic kidney disease.
- To elucidate how CKD affects the function of renal transporters and their impact on drug pharmacokinetics and pharmacodynamics.
Main Methods:
- This study synthesizes current research on renal transporter expression and function in CKD.
- Analysis of existing literature on drug-drug interactions mediated by renal transporters in the context of kidney disease.
Main Results:
- CKD alters the expression and function of key renal membrane transporters.
- Transporter dysfunction in CKD contributes to the accumulation of uremic toxins and affects drug elimination and efficacy.
- Renal transporters are critical targets for therapeutic interventions and understanding drug interactions in CKD.
Conclusions:
- Altered membrane transporter function is a key feature of chronic kidney disease pathophysiology.
- Understanding these changes is essential for optimizing drug therapy, predicting drug-drug interactions, and managing CKD patients.
More Related Videos
Related Concept Videos
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Membrane Proteins
Membrane Transporters
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Drug Elimination by Renal Route: Tubular Secretion
Facilitated Diffusion
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...

